Drug Trial Radar · NCT00908349
Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
Last checked: Nov 19, 2026Latest source record: May 31, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
214
Actual
Start
Jun 2009
Primary completion
Nov 2011
Study completion Nov 2011
Sponsor
- Lead sponsor
- Supernus Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 25, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 66 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR)
Conditions
- Partial Epilepsy
Interventions
Oxcarbazepine XRDrug
Open Label Study
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Seizure RateTime frame: one year
Locations
58 sites in 8 countries. Site status is shown where the registry gives one.
Site not named
Huntsville, Alabama
Site not named
Northport, Alabama
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Little Rock, Arkansas
Site not named
Riverside, California
Site not named
West Los Angeles, California
Site not named
Aurora, Colorado
Site not named
Jacksonville, Florida
Site not named
Miami, Florida
Site not named
Sarasota, Florida
Site not named
Springfield, Illinois
Site not named
Lexington, Kentucky
Site not named
Bethesda, Maryland
Site not named
Missoula, Montana
Site not named
New York, New York
Site not named
Oklahoma City, Oklahoma
Site not named
Nashville, Tennessee
Site not named
Baytown, Texas
Site not named
Temple, Texas
Site not named
Blagoevgrad, Bulgaria
Site not named
Pleven, Bulgaria
Site not named
Rousse, Bulgaria
Site not named
Sofia, Bulgaria
Site not named
Varna, Bulgaria
Site not named
Calgary, Alberta, Canada
Site not named
Greenfield Park, Quebec, Canada
Site not named
Dubrovnik, Croatia
Site not named
Zagreb, Croatia
Site not named
Aguascalientes, Mexico
Site not named
Puebla City, Mexico
Site not named
Col. Las Palmas, Chihuahua, Mexico
Site not named
Col. Guillermina, Durango, Mexico
Site not named
Guadalajara, Jalisco, Mexico
Site not named
Zapopan, Jalisco, Mexico
Site not named
Mexico City, Mexico City, Mexico
Site not named
San Luis Potosí City, San Luis Potosí, Mexico
Site not named
Giżycko, Poland
Site not named
Katowice, Poland
Site not named
Krakow, Poland
Showing 40 of 58 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.